Bionano Genomics files to sell 12.25M shares of common stock for holders

Bionano Genomics ( NASDAQ: BNGO ) filed a prospectus related to the re-sale of up to 12,250,000 shares of common stock by the Selling Security holder. The offering includes up to 2,250,000 upfront shares and up to 10,000,000 shares of common stock issuable upon conversion of the Debentures. This prospectus is not an offer to sell.

Filing More on Bionano Genomics Bionano Genomics, Inc. (BNGO) Q1 2024 Earnings Call Transcript Bionano stock climbs 7% in wake of Q1 report, software upgrades Bionano Genomics up 7% on narrowed quarterly loss, revenue beat Seeking Alpha’s Quant Rating on Bionano Genomics Historical earnings data for Bionano Genomics.